Urea Cycle Disorder Clinical Trial
Official title:
Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)
THRIVE is an observational study that will collect information on patients with UCDs. THRIVE will follow enrolled participants for up to 10 years. As an observational study, enrolled patients will not be required to make any additional office visits or take any medicine outside of normal care.
UCDs disproportionately affect children and females: depending on the severity of the defect, a UCD can manifest shortly after birth or later in life. This study will track long-term outcomes in UCD patients and effects of ammonia-scavenging agents on neuropsychological functions of UCD patients. This is a non-interventional, multi-center registry to be conducted in patients with UCDs. Investigators will prescribe treatments based on usual clinical practice, and there will be no restrictions on the use of commercially available medications. As an observational study, this study will not change the patient/ healthcare provider relationship, nor influence the healthcare provider's drug prescription or the therapeutic management of the patient. Patients with UCDs will be recruited and invited to attend a Baseline visit. After eligible patients are enrolled, retrospective and baseline data will be collected. Patients will be followed for up to 10 years, during which time they will be assessed by their healthcare provider. Patients and healthcare provider will be asked to report episodes of hyperammonemic crisis, available ammonia values, and other information. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03933410 -
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
|
Phase 2 | |
| Completed |
NCT03064048 -
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD
|
N/A | |
| Recruiting |
NCT04612764 -
Liver Disease in Urea Cycle Disorders
|
||
| Completed |
NCT05330039 -
Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)
|
||
| Completed |
NCT03721367 -
Chronic Liver Disease in Urea Cycle Disorders
|
||
| Completed |
NCT03911089 -
A Collection of Case Studies in Infants With UCD to Evaluate Infant Growth and the Safety of a New Medical Food for UCD
|
N/A | |
| Terminated |
NCT03181828 -
Manipulating the Gut Microbiome Study
|
Phase 1/Phase 2 | |
| Completed |
NCT00472732 -
Neurologic Injuries in Adults With Urea Cycle Disorders
|
N/A | |
| Recruiting |
NCT05076318 -
Dysregulated Urea-synthesis at Terminal Uremia
|
N/A | |
| Completed |
NCT03179878 -
Safety and Tolerability of SYNB1020-CP-001
|
Phase 1 | |
| Recruiting |
NCT04602325 -
Systemic Biomarkers of Brain Injury From Hyperammonemia
|
||
| Withdrawn |
NCT03884959 -
A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients
|
Phase 2 | |
| Recruiting |
NCT04908319 -
Hepatic Histopathology in Urea Cycle Disorders
|
||
| Completed |
NCT03335488 -
Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)
|
Phase 4 | |
| Completed |
NCT02246218 -
A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders
|
Phase 4 | |
| Completed |
NCT04248062 -
Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
|
||
| Completed |
NCT05706714 -
Th1, Th2, Th17 Phenotype in Urea Cycle Disorders
|
||
| Terminated |
NCT03343756 -
HepaStem Long-Term Safety Registry
|